🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07402265
Recruiting Not applicable

Piloting a Brief, Online Intervention for Suicidality in Sexual and Gender Minority Youth

NCT07402265 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-02-01
Last updated
2026-08-21

Condition(s) studied

Suicidal ThoughtsSexual and Gender MinoritiesYouth

Investigational drug(s) / intervention(s)

KindMind

KindMind: This intervention is hosted on Wix-com and involves multiple self-guided modules in which participants are taught how to use self-compassion and/or self-neutrality to reduce suicidal thoughts. This intervention is tailored to sexual and gender minority youth.

Study summary

Sexual and gender minority youth (i.e., LGBTQ+ individuals) are at elevated risk for suicidal thoughts compared to cisgender/heterosexual youth and there is increased demand for programs and treatments tailored to this population. The current study seeks to pilot a brief, online, self-guided intervention for suicidal thoughts designed for sexual and gender minority youth to test if this intervention is acceptable to this population and if completing this intervention significantly decreases suicidal thoughts.

Eligibility

Sex
ALL
Min age
13 Years
Max age
25 Years
Healthy volunteers
No
Inclusion Criteria: * Resident of Canada * Fluent in English * Youth (i.e., 13-25 years) * Identifies as a sexual and/or gender minority (i.e., any sexual identity excluding heterosexual and/or any gender identity excluding cisgender) * Endorses experiencing any suicidal ideation within the past 6 months * Access to a computer and able to participate virtually Exclusion Criteria: * Does not meet the inclusion criteria

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Western University London Ontario Recruiting

More Western University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07402265 on ClinicalTrials.gov ↗ ← All trials in Canada